Clinical assessment for an enhanced targeted next generation sequencing assay for tuberculosis (PRJCA034623)
In this study, we propose an enhanced tNGS method. We prospectively enrolled 181 clinically suspected TB patients to demonstrate the tNGS assay's capability in diagnosing TB, drug-resistant TB, and distinguishing other common respiratory pathogens in a clinical setting.